Status:

COMPLETED

Novel Biophotonics Methodology for Colon Cancer Screening

Lead Sponsor:

Endeavor Health

Collaborating Sponsors:

Northwestern University

University of Chicago

Conditions:

Colon Cancer

Eligibility:

All Genders

18+ years

Brief Summary

This is a proposal to establish a Bioengineering Research Partnership (BRP). The major objective of the BRP is to refine and provide comprehensive, definitive multi-center validation of these novel me...

Detailed Description

Background and Significance highlights the impracticality to provide total colonic evaluation for the entire population. Risk-stratification via exploitation of the "field effect" is an attractive app...

Eligibility Criteria

Inclusion

  • Subject is 18 years old or older and is having a colonoscopy procedure.

Exclusion

  • Concurrent usage of anticoagulation or blood thinner medication within the last 7 days that would preclude Hx of Inflammatory Bowel Disease/Colitis/Chemotherapy.

Key Trial Info

Start Date :

September 1 2009

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 1 2013

Estimated Enrollment :

857 Patients enrolled

Trial Details

Trial ID

NCT04031963

Start Date

September 1 2009

End Date

May 1 2013

Last Update

July 25 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

NorthShore Univeristy HealthSystems

Evanston, Illinois, United States, 60201

Novel Biophotonics Methodology for Colon Cancer Screening | DecenTrialz